| |
| |
|
| Insider
Information: |
Reeve Emma |
| Relationship: |
|
| City: |
Waltham |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
19,668 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$370,664 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
19,668 |
|
|
| Total
Value |
$370,664 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -87.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
PAREXEL International |
PRXL |
Corp. VP & Interim CFO |
2016-12-07 |
8,468 |
|
0 |
Premium* |
|
|
Constellation Pharmaceuticals Inc |
CNST |
|
2021-02-22 |
0 |
2019-11-05 |
0 |
Premium* |
|
|
PTC Therapeutics, Inc. |
PTCT |
|
2024-02-15 |
11,200 |
2020-01-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
49 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PRXL |
PAREXEL International |
Corp. VP & Interim CFOOfficer |
• – – |
2016-07-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
6,120 |
|
- |
|
| CNST |
Constellation Pharmaceuti... |
Chief Financial Officer |
• – – |
2020-02-10 |
4 |
S |
$35.00 |
$7,000 |
D/D |
(200) |
0 |
0 |
% |
|
| CNST |
Constellation Pharmaceuti... |
Chief Financial Officer |
• – – |
2020-02-10 |
4 |
OE |
$7.60 |
$1,520 |
D/D |
200 |
200 |
0 |
- |
|
| CNST |
Constellation Pharmaceuti... |
Chief Financial Officer |
• – – |
2021-02-17 |
4 |
OE |
$8.04 |
$3,296 |
D/D |
410 |
410 |
0 |
- |
|
| CNST |
Constellation Pharmaceuti... |
Chief Financial Officer |
• – – |
2021-02-17 |
4 |
AS |
$37.56 |
$15,398 |
D/D |
(410) |
0 |
0 |
% |
|
| CNST |
Constellation Pharmaceuti... |
Chief Financial Officer |
• – – |
2020-06-08 |
4 |
AS |
$36.59 |
$22,118 |
D/D |
(589) |
0 |
0 |
% |
|
| CNST |
Constellation Pharmaceuti... |
Chief Financial Officer |
• – – |
2020-06-08 |
4 |
OE |
$7.60 |
$4,476 |
D/D |
589 |
589 |
0 |
- |
|
| CNST |
Constellation Pharmaceuti... |
Chief Financial Officer |
• – – |
2020-04-09 |
4 |
AS |
$35.02 |
$24,513 |
D/D |
(700) |
0 |
0 |
% |
|
| CNST |
Constellation Pharmaceuti... |
Chief Financial Officer |
• – – |
2020-04-09 |
4 |
OE |
$7.60 |
$5,449 |
D/D |
700 |
589 |
0 |
- |
|
| CNST |
Constellation Pharmaceuti... |
Chief Financial Officer |
• – – |
2020-04-17 |
4 |
AS |
$35.29 |
$26,820 |
D/D |
(760) |
0 |
0 |
% |
|
| CNST |
Constellation Pharmaceuti... |
Chief Financial Officer |
• – – |
2020-04-17 |
4 |
OE |
$6.61 |
$5,024 |
D/D |
760 |
760 |
0 |
- |
|
| CNST |
Constellation Pharmaceuti... |
Chief Financial Officer |
• – – |
2019-11-05 |
4 |
OE |
$6.61 |
$6,610 |
D/D |
1,000 |
1,000 |
0 |
- |
|
| CNST |
Constellation Pharmaceuti... |
Chief Financial Officer |
• – – |
2019-11-05 |
4 |
AS |
$15.50 |
$15,504 |
D/D |
(1,000) |
0 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Director |
– • – |
2020-12-15 |
4 |
OE |
$33.02 |
$33,945 |
D/D |
1,028 |
2,678 |
0 |
- |
|
| CNST |
Constellation Pharmaceuti... |
Chief Financial Officer |
• – – |
2021-02-18 |
4 |
OE |
$8.04 |
$8,844 |
D/D |
1,100 |
1,100 |
0 |
- |
|
| CNST |
Constellation Pharmaceuti... |
Chief Financial Officer |
• – – |
2021-02-18 |
4 |
AS |
$37.58 |
$41,343 |
D/D |
(1,100) |
0 |
0 |
% |
|
| CNST |
Constellation Pharmaceuti... |
Chief Financial Officer |
• – – |
2020-02-12 |
4 |
OE |
$8.04 |
$8,868 |
D/D |
1,103 |
1,103 |
0 |
- |
|
| CNST |
Constellation Pharmaceuti... |
Chief Financial Officer |
• – – |
2020-02-12 |
4 |
AS |
$35.02 |
$38,624 |
D/D |
(1,103) |
0 |
0 |
% |
|
| CNST |
Constellation Pharmaceuti... |
Chief Financial Officer |
• – – |
2020-04-14 |
4 |
OE |
$8.76 |
$10,731 |
D/D |
1,225 |
1,225 |
0 |
- |
|
| CNST |
Constellation Pharmaceuti... |
Chief Financial Officer |
• – – |
2020-04-14 |
4 |
AS |
$35.20 |
$43,123 |
D/D |
(1,225) |
0 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Director |
– • – |
2020-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
1,650 |
1,650 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Director |
– • – |
2021-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,650 |
4,328 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Director |
– • – |
2020-12-14 |
4 |
AS |
$68.00 |
$134,096 |
D/D |
(1,972) |
1,650 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Director |
– • – |
2020-12-14 |
4 |
OE |
$33.02 |
$65,115 |
D/D |
1,972 |
2,622 |
0 |
- |
|
| PRXL |
PAREXEL International |
Corp. VP & Interim CFO |
• • – |
2016-12-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,348 |
8,468 |
0 |
- |
|
49 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
